Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Javier Cambronero-Santos"'
Autor:
Yovana Rodríguez-Maldonado, Teresa Sánchez-Moreno de Juan, Alicia Ruiz de la Hermosa, Inés Naranjo-Peña, Virginia de Gea-López, Javier Cambronero-Santos
Publikováno v:
Cirugía y Cirujanos, Vol 91, Iss 4 (2023)
Antecedentes: Una ostomía influye significativamente en la vida de la persona, alterando su esfera biopsicosocial y sexual, y afectando a sus relaciones interpersonales. Material y método: Estudio observacional, descriptivo y transversal. Mediante
Externí odkaz:
https://doaj.org/article/563d786010f6449fbe1ad324f1cbe003
Autor:
Steven A. Kaplan, Javier Cambronero Santos, Steve Foley, John Hairston, Kevin T. McVary, Rita M. Kristy, Sender Herschorn, Nurul Choudhury
Publikováno v:
Urology. 147:235-242
OBJECTIVE To analyze the safety of mirabegron add-on therapy in men with overactive bladder symptoms concurrently receiving tamsulosin for lower urinary tract symptoms associated with benign prostatic hyperplasia. METHODS The Phase 4 PLUS study compr
Publikováno v:
Archivos espanoles de urologia. 73(2)
The questionnaire International Prostate Symptom Score (IPSS) is well known and used in clinical practice as diagnostic tool and allows for obtaining a total score regarding the severity of the urinary symptoms. The objective of this analysis is to d
Autor:
David R. Staskin, Kevin T. McVary, Sender Herschorn, Christopher R. Chapple, John Hairston, Steven A. Kaplan, Steve Foley, Nurul Choudhury, Carol R. Schermer, Javier Cambronero Santos, Rita M Kristy
Publikováno v:
Journal of Urology
Journal of Urology, Elsevier, 2020, 203 (6), pp.1171-1171. ⟨10.1097/ju.0000000000000738.01⟩
Journal of Urology, Elsevier, 2020, 203 (6), pp.1171-1171. ⟨10.1097/ju.0000000000000738.01⟩
PLUS investigated the efficacy and safety of mirabegron add-on therapy in men with overactive bladder symptoms receiving tamsulosin for underlying lower urinary tract symptoms attributable to benign prostatic hyperplasia.In this phase 4 study a 4-wee
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9120fbe0f5a8161fe87a79b60473390
https://hal.archives-ouvertes.fr/hal-03228620
https://hal.archives-ouvertes.fr/hal-03228620
Autor:
John C. Hairston, Christopher R. Chapple, Javier Cambronero Santos, David R. Staskin, Steven Kaplan, Kevin T. McVary, Steve Foley, Sender Herschorn, Nurul Choudhury, Rita M Kristy, Carol R. Schermer
Publikováno v:
Journal of Urology. 201
INTRODUCTION AND OBJECTIVES:In men, overactive bladder (OAB) symptoms commonly overlap with those of benign prostatic hyperplasia (BPH), but limited data are available on the use of OAB medications...
Autor:
Steven A. Kaplan, Sender Herschorn, Kevin T. McVary, David Staskin, Christopher Chapple, Steve Foley, Javier Cambronero Santos, Rita M. Kristy, Nurul Choudhury, John Hairston, Carol R. Schermer
Publikováno v:
Journal of Urology. 203:1171-1171
Autor:
Juan Manuel Palacios-Moreno, Timothy Wilson, François Giuliano, Javier Cambronero Santos, Michael J. Manyak, Janet Plastino, Raymond C. Rosen, Claus G. Roehrborn, Erik P.M. Roos, Dimitrios Karanastasis
Publikováno v:
BJU international. 121(4)
Objective To prospectively assess the impact of the fixed-dose combination (FDC) of the 5α-reductase inhibitor (5ARI), dutasteride 0.5 mg and the α1-adrenoceptor antagonist, tamsulosin 0.4 mg (DUT-TAM FDC) therapy on sexual function domain scores i
Autor:
Marcus J. Drake, Stavros Athanasiou, Scott MacDiarmid, Sender Herschorn, Christopher R. Chapple, Javier Cambronero Santos, Moses Huang, Matthias Stoelzel, Emad Siddiqui, David Mitcheson, Ahmet Adil Esen
Publikováno v:
International Journal of Clinical Practice
Drake, M J, MacDiarmid, S, Chapple, C R, Esen, A, Athanasiou, S, Cambronero Santos, J, Mitcheson, D, Herschorn, S, Siddiqui, E, Huang, M & Stoelzel, M 2017, ' Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE) ', International Journal of Clinical Practice, vol. 71, no. 5, e12944 . https://doi.org/10.1111/ijcp.12944
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Drake, M J, MacDiarmid, S, Chapple, C R, Esen, A, Athanasiou, S, Cambronero Santos, J, Mitcheson, D, Herschorn, S, Siddiqui, E, Huang, M & Stoelzel, M 2017, ' Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE) ', International Journal of Clinical Practice, vol. 71, no. 5, e12944 . https://doi.org/10.1111/ijcp.12944
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Aims/objectives: In the BESIDE study, combination therapy (antimuscarinic [solifenacin] and β3-adrenoceptor agonist [mirabegron]) improved efficacy over solifenacin monotherapy without exacerbating anticholinergic side effects in overactive bladder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d01bd1aea42ca57f88a63df8acd18366
https://avesis.deu.edu.tr/publication/details/a04b6003-d53d-4708-baff-681a43b2c190/oai
https://avesis.deu.edu.tr/publication/details/a04b6003-d53d-4708-baff-681a43b2c190/oai
Autor:
Carlos, Müller-Arteaga, Salvador, Arlandis Guzmán, María Fernanda, Lorenzo Gómez, Carlos, Errando-Smet, Raquel, González López, Javier, Cambronero Santos, José Luis, Gutiérrez Baños, Manuel, Sánchez Marcos, Antonio, Ortiz Gamiz, Sergio, Merino Salas, Roberto, Martínez Rodriguez, Ivan, Olano Grasa
Publikováno v:
Archivos espanoles de urologia. 69(9)
To define the different characteristics of transdermal oxybutynin (TO) for the treatment of overactive bladder in adults, to know the barriers for the use of this drug and to establish proposals to minimize these barriers.Local sessions were held wit
Publikováno v:
Archivos espanoles de urologia. 63(3)
This article aims to analyse the use of solifenacin in the treatment of overactive bladder in order to show its efficacy and safety within the framework of the scientific evidence.The available scientific literature was reviewed, including most of th